Join the Microbiome Signature Project: Outcomes and Future Outlook event at Hubnordic in Ørestad, Copenhagen and learn more about recent investments and establishments in the region, meet international talent and for an exclusive presentation of a microbiome hub benchmarking study and a possible future microbiome platform for the Medicon Valley region.
The Microbiome Signature Project: Outcomes and Future Outlook event offers a place gathering the region’s leading microbiome scientists and companies, research talents and startups, key opinion leaders and funding partners.
Date: Tuesday 7 June 2022
Rising Stars in Medicon Valley Microbiome Research
This is an MVA Microbiome Network meeting organised in partnership with the Microbiome Signature Project, that will feature several up and coming researchers in Medicon Valley working on the microbiome.
Registration is required separately and the event is open to all. To find out more and register, please see the event page here.
Lunch & networking
The Medicon Valley Ecosystem
Overarching trends in microbiome research in Medicon Valley over the past two years.
Tapping into the Microbiome Potential
Investments and establishments in the Medicon Valley region
Camilla Münter, Investment Manager - Life Sciences, Copenhagen Capacity
Micael Györei, Senior Investment Advisor - Life Sciences, Invest in Skåne
Oliver Bates, CEO, Viramal
Ömer Özkan, CEO & Founder, Enbiosis Biotechnology
Joining a Leading Microbiome Hub
Why international talents join Medicon Valley
Exploring the potential for a Medicon Valley Microbiome Research and Innovation Platform
Findings from a benchmarking study on microbiome research hubs in Europe and US
Panel discussion: Reflections on the findings from the microbiome hub benchmarking study, and the way aheadSarah Lidé, Senior Strategy & Project Manager, Medicon Valley Alliance
Arthur Krause, Consultant in the Global Strategy Group for Life Sciences, KPMG Switzerland
Dina Petranovic Nielsen, CPO & CSO, Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark
Mani Arumugam, Associate Professor, Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen
Kristine Koppelhus, Director of Scientific and Public Affairs, BioGaia
Conclusions & the Way Forward
Summary of the three-year project and how to keep momentum going forward
Mingle and networking
CEO, Medicon Valley Alliance
COO, Copenhagen Capacity
Managing Director, Invest in Skåne
Investment Manager - Life Science, Copenhagen Capacity
Strategy & Talent Acquisition Lead, Copenhagen Capacity
Senior Strategy & Project Manager, Medicon Valley Alliance
Senior Investment Advisor - Life Sciences, Invest in Skåne
Head of Global HR Services,
CEO & Founder,
CPO & CSO, Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark
Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen
PhD, Bioinformatics Specialist, Clinical Microbiomics
Consultant in the Global Strategy Group for Life Sciences, KPMG Switzerland
Director of Scientific and Public Affairs, BioGaia
About the Organisers
The Microbiome Signature Project: Outcomes and Future Outlook event is organised by the Greater Copenhagen Microbiome Signature Project, which seeks to position the Medicon Valley area as a global centre for microbiome research. The three-year project aims to enhance collaboration, boost private investments in research and innovation, establish international research facilities and activities, and attract talent to both public and private funded research environments. The project is jointly managed and run by Medicon Valley Alliance, Copenhagen Capacity and Invest in Skåne, and is supported by Interreg Öresund-Kattegat-Skagerrak and Greater Copenhagen.
In partnership with